I have read $500,000 per year per patient is being used for revenue projections by some of the pundits covering SRPT. No way that amount would be covered by insurance.
there are many drugs that cost close to or over hundreds of thousands a year to treat diseases with bigger patient populations than DMD. the insurance companies still pay. obviously you are attempting to bash.
John Kelly is sorry for the "poor" insurance companies? Hah! Fell sorry for yourself and your losses on shorting SRPT!
u'd b suprized how much they take these poor insurance companies for.
go short then
Sentiment: Strong Buy